産科救急マニュアル

出版社: 中山書店
著者:
発行日: 2021-04-07
分野: 臨床医学:外科  >  産婦人科学
ISBN: 9784521749112
電子書籍版: 2021-04-07 (初版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

9,900 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

9,900 円(税込)

商品紹介

不意打ちのように遭遇する母体・胎児の急変に対し,3つの構成から成る.
(1)基本手技編:周産期救急にスポットを当てたバイタルサイン・検査・救急蘇生.
(2)症候編:産科臨床における前景疑問(起こりうる疑問)に対する回答.検査,初期対応,
      フローチャートによる診断までの流れを図解.
(3)疾患編:妊産婦の状態と施設の状況に応じた対応の要点についてエビデンスをもとに紹介.

目次

  • I章 基本手技編
     理学所見・バイタイルサインの判断
      血圧・脈拍の変化
      呼吸障害
      意識障害
     検査法
      血液検査
      尿検査
      腹部超音波検査
      心電図・心エコー
      CT・MRI検査
     治療対応
      呼吸補助
      循環補助
      輸液・輸血
      準備すべき薬剤・器材

    II章 症候編
      妊娠初期の下腹部痛が生じたら?
      妊産婦に腰背部痛が生じたら?
      妊産婦に突然の頭痛が生じたら?
      妊産婦に高血圧が確認されたら?
      妊産婦に急性の肝酵素上昇が生じたら?
      妊産婦に血糖値異常を伴う意識障害が生じたら?
      分娩進行中に遷延性胎児徐脈が出現したら?
      無痛分娩中に母体の状態が急変したら?
      分娩時に生じた痙攣・意識障害への対応は?
      経腟分娩後の危機的出血への初期対応は?
      帝王切開中に子宮出血が止血困難である場合の緊急処置は?
      産褥期の労作時息切れを認めたら?
      重症な妊娠悪阻への対応は?

    III章 疾患編
      異所性妊娠を疑ったら?
      頸管妊娠あるいは帝王切開瘢痕部妊娠を疑ったら?
      妊娠中に虫垂炎を疑ったら?
      高マグネシウム血症への対応は?
      妊産婦のアナフィラキシーショックへの対応は?
      妊婦に喘息発作が生じたら?
      妊婦に甲状腺クリーゼを疑ったら?
      前置胎盤・低置胎盤における妊娠中・分娩時の出血の対応は?
      臍帯下垂・臍帯脱出への対応は?
      双胎一児死亡への対応は?
      常位胎盤早期?離の診断と対応のポイントは?
      常位胎盤早期?離後の胎児死亡への対応は?
      羊水塞栓症が疑われる状態とその対応は?
      子宮破裂を疑ったら?
      産道裂傷・産道血腫への対応は?
      子宮内反症を疑ったら?
      死戦期帝王切開の決断とその意義は?

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I章 基本手技編

P.5 掲載の参考文献
1) Ashrafi R, Curtis SL. Heart disease and pregnancy. Cardiol Ther 2017 ; 6 : 157-73.
2) Meah VL, et al. Cardiac output and related haemodynamics during pregnancy : a series of meta-analyses. Heart 2016 ; 102 : 518-26.
3) Bernstein IM, et al. Plasma volume expansion in early pregnancy. Obstet Gynecol 2001 ; 97 : 669-72.
4) 日本産科婦人科学会, 日本産婦人科医会編・監. CQ418-1 産後の異常出血の予防ならびに対応は? 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.260-3.
5) Nathan HL, et al. Shock index : an effective predictor of outcome in postpartum haemorrhage? BJOG 2015 ; 122 : 268-75.
6) Sheldon WR, et al. Postpartum haemorrhage management, risks, and maternal outcomes : findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 2014 ; 121 : 5-13.
7) Leduc D, et al. Active Management of the third stage of labour : prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 2009 ; 31 : 980-93.
8) Flo K, et al. A longitudinal study of the relationship between maternal cardiac output measured by impedance cardiography and uterine artery blood flow in the second half of pregnancy. BJOG 2010 ; 117 : 837-44.
9) Ueland K, Hansen JM. Maternal cardiovascular dynamics. II. Posture and uterine contractions. Am J Obstet Gynecol 1969 ; 103 : 1-7.
10) Kametas NA, et al. Maternal cardiac function in twin pregnancy. Obstet Gynecol 2003 ; 102 : 806-15.
P.10 掲載の参考文献
1) Rocke DA, et al. Relative risk analysis of factors associated with difficult intubation in obstetric anesthesia. Anesthesiology 1992 ; 77 : 67-73.
2) Boutonnet M, et al. Mallampati class changes during pregnancy, labour, and after delivery : can these be predicted? Br J Anaesth 2010 ; 104 : 67-70.
4) Elkus R, Popovich J Jr. Respiratory physiology in pregnancy. Clin Chest Med 1992 ; 13 : 555-65.
5) Lim VS, et al. Acid-base regulation in pregnancy. Am J Physiol 1976 ; 231 : 1764-9.
6) Bobrowski RA. Pulmonary physiology in pregnancy. Clin Obstet Gynecol 2010 ; 53 : 285-300.
7) Nakai A, et al. Characteristics of pregnant Japanese women who required hospitalization for treatment of pandemic (H1N1) 2009 : low mortality rate may be due to early antiviral use. J Infect 2011 ; 62 : 232-3.
P.15 掲載の参考文献
1) 日本救急医学会指導医・専門医制度委員会, 日本救急医学専門医認定委員会編. 救急診療指針 改訂第5版. 東京 : へるす出版 ; 2018. p.260-71.
2) 望月礼子. 産科エマージェンシー臨床推論. 大阪 : メディカ出版 ; 2020. p.68-73.
3) 『ACECガイドブック 2019』編集委員会, 意識障害に関するERにおける標準化小委員会編. ACECガイドブック 2019. 東京 : へるす出版 ; 2019. p.15-9.
4) Yoshida K, et al. Stroke associated with pregnancy and puerperium : a nationwide study by the Japan Stroke Society. Stroke 2017 ; 48 : 276-82.
P.21 掲載の参考文献
1) Cunningham F, et al, editors. Williams Obstetrics. 24th ed. New York : McGraw-HIll ; 2014. p.53, 1287-91.
2) Landon MB, et al, editors. Gabbe's Obstetrics : Normal and Problem Pregnancies. 8th ed. Philadelphia : Elsevier ; 2020. p.48, 50, 60, 369.
3) Auerbach M, Landy HJ. Anemia in pregnancy. In : Post TW, editor. UpToDate. Waltham : UpToDate ; 2020. 1.
4) 厚生労働省. 日本人の食事摂取基準 (2020年版). 2020. (最終閲覧 2020年11月25日)
5) Said JM, et al. Altered reference ranges for protein C and protein S during early pregnancy : Implications for the diagnosis of protein C and protein S deficiency during pregnancy. Thromb Haemost 2010 ; 103 : 984-8.
6) Murphy N, et al. Gestation-specific D-dimer reference ranges : a cross-sectional study. BJOG 2015 ; 122 : 395-400.
7) Smith MC, et al. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG 2008 ; 115 : 109-12.
8) Hernandez TL, et al. Patterns of glycemia in normal pregnancy : should the current therapeutic targets be challenged? Diabetes Care 2011 ; 34 : 1660-8.
9) 今川彰久ほか. 1型糖尿病調査研究委員会報告-劇症1型糖尿病の新しい診断基準 (2012). 糖尿病 2012 ; 55 : 815-20.
10) 川崎英二ほか. 妊娠関連発症1型糖尿病に関する全国調査. 糖尿病と妊娠 2006 ; 6 : 104-7.
11) Watts DH, et al. C-reactive protein in normal pregnancy. Obstet Gynecol 1991 ; 77 : 176-80.
Bauer KA. Maternal adaptations to pregnancy : hematologic changes. In : Post TW, editor. UpToDate. Waltham : UpToDate ; 2020. 8.
P.24 掲載の参考文献
1) 日本薬剤師会ウェブサイト https://www.nichiyaku.or.jp/ (最終閲覧 2020年11月19日)
2) 日本産科婦人科学会. 日本産婦人科医会編・監. 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.168.
3) 日本泌尿器科学会ほか編. 尿路結石症診療ガイドライン 2013年版. 東京 : 金原出版 : 2013. p.37.
P.29 掲載の参考文献
1) 田中宏和. エキスパートに聞く産婦人科超音波ABC 13. 産科救急. 産科と婦人科 2019 ; 89 : 1115-8.
2) 谷垣伸治. 産婦人科救急の超音波検査. 超音波医学 2011 ; 38 : 413-20.
3) 山田博康. 消化器領域 消化管. 森秀明編. レジデント・臨床検査技師のためのはじめての超音波検査. 東京 : 文光堂 ; 2019. p.119-39.
4) 森秀明. 消化器領域 肝臓. 森秀明編. レジデント・臨床検査技師のためのはじめての超音波検査. 東京 : 文光堂 ; 2019. p.54-79.
5) 西川かおり. 消化器領域 胆道 (胆嚢・胆管). 森秀明編. レジデント・臨床検査技師のためのはじめての超音波検査. 東京 : 文光堂 ; 2019. p.80-92.
6) 森秀明. 消化器領域 脾臓. 森秀明編. レジデント・臨床検査技師のためのはじめての超音波検査. 東京 : 文光堂 ; 2019. p.108-18.
7) 西川かおり. 消化器領域 膵臓. 森秀明編. レジデント・臨床検査技師のためのはじめての超音波検査. 東京 : 文光堂 ; 2019. p.93-107.
8) 千葉裕. 泌尿器科領域 腎・腎盂・尿管. 森秀明編. レジデント・臨床検査技師のためのはじめての超音波検査. 東京 : 文光堂 ; 2019. p.188-206.
9) 亀田徹. 超音波検査を用いた下大静脈の観察による循環動態の評価. 日救急医会誌 2013 ; 24 : 903-15.
10) 亀田慎也. 救急医学領域FASTとE-FAST. 森秀明編. レジデント・臨床検査技師のためのはじめての超音波検査. 東京 : 文光堂 ; 2019. p.336-43.
11) Brosens IA, et al. Severe spontaneous hemoperitoneum in pregnancy may be linked to in vitro fertilization in patients with endometriosis : a systematic review. Fertil Steril 2016 ; 106 : 692-703.
P.36 掲載の参考文献
1) 日本循環器学会ほか編. 不整脈薬物治療ガイドライン 2020年改訂版. 2020. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Ono.pdf (最終閲覧 2020年11月19日)
2) Seth R, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol 2007 ; 49 : 1092-8.
3) Ishibashi K, et al. Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndrome. Heart 2017 ; 103 : 1374-9.
4) Rossi A, et al. Quantitative cardiovascular magnetic resonance in pregnant women : cross-sectional analysis of physiological parameters throughout pregnancy and the impact of the supine position. J Cardiovasc Magn Reson 2011 ; 13 : 31-7.
5) 厚生労働省科学研究「周産期 (産褥性) 心筋症の, 早期診断検査確立研究の継続と診断ガイドライン作成」班ほか編. 周産期心筋症診療の手引き. 東京 : 中外医学社 ; 2019. p.27-37.
6) Kamiya AC, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J 2011 ; 75 : 1975-81.
7) Hilfiker-Kleiner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy : a multicentre randomized study. Eur Heart J 2017 ; 38 : 2671-9.
P.42 掲載の参考文献
1) Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol 1997 ; 70 : 130-9.
2) Schulze-Rath R, et al. Are pre- or postnatal diagnostic X-rays a risk factor for childhood cancer? A systematic review. Radiat Environ Biophys 2008 ; 47 : 301-12.
3) Rajaraman P, et al. Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer : case-control study. BMJ 2011 ; 342 : d472.
4) Ray JG, et al. Major radiodiagnostic imaging in pregnancy and the risk of childhood malignancy : a population-based cohort study in Ontario. PLoS Med 2010 ; 7 : e1000337.
5) Rajaram S, et al. Effect of antenatal iodinated contrast agent on neonatal thyroid function. Br J Radiol 2012 ; 85 : e238-42.
6) Ray JG, et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA 2016 ; 316 : 952-61.
7) Chartier AL, et al. The safety of maternal and fetal MRI at 3 T. AJR Am J Roentgenol 2019 ; 213 : 1170-3.
日本産科婦人科学会, 日本婦人科医会編・監. 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020.
ACR-SPR Practice Parameter for Imaging Pregnant or Potentially Pregnant Adolescents and Women with Ionizing Radiation. 2018.
ACOG Committee on Obstetric Practice. ACOG Committee Opinion Number 723 : Guidelines for Diagnostic Imaging During Pregnancy and Lactation. 2017.
ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. 2020.
坪山尚寛. 妊娠中CT, MRI の安全性と産科救急. 画像診断 2019 ; 39 : 675-84.
P.49 掲載の参考文献
1) 浅井隆. 緊急気道確保 : 器具と外科的処置 (1) エアウェイ・正門上器具. 日本臨床麻酔学会雑誌 2014 ; 34 (4) : 608-12.
2) 田中竜馬ほか訳. ヘスとマカレックのTHE人工呼吸ブック. 第2版. 東京 : MEDSi ; 2015. p.149-53.
P.56 掲載の参考文献
1) 日本蘇生協議会監. JRC蘇生ガイドライン 2015. 東京 : 医学書院 ; 2016. p.8, 10.
2) Jeejeebhoy FM, et al. Cardiac arrest in pregnancy : a scientific statement from the American Heart Association. Circulation 2015 ; 132 : 1747-73.
3) Lavonas EJ, et al. Part 10 : Special circumstances of resuscitation : 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015 ; 132 : S501-18.
4) Ramanathan K, et al. Extracorporeal membrane oxygenation in pregnancy : an analysis of the Extracorporeal Life Support Organization Registry. Crit Care Med 2020 ; 48 : 696-703.
5) American Heart Association. ACLSプロバイダーマニュアルAHAガイドライン 2015 準拠. 東京 : シナジー ; 2017. p.145-52.
6) Lipman S, et al. The Society for Obstetric Anesthesia and Perinatology consensus statement on the management of cardiac arrest in pregnancy. Anesth Analg 2014 ; 118 : 1003-16.
P.64 掲載の参考文献
1) 亀井良政ほか. 産科の出血性ショック その現状と輸血療法. 産婦治療 2009 ; 99 : 279-83.
2) Duthie SJ, et al. Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol 1991 ; 38 : 119-24.
3) Charbit B, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007 ; 5 : 266-73.
4) Matsunaga S, et al. The clinical efficacy of fibrinogen concentrate in massive obstetric haemorrhage with hypofibrinogenaemia. Sci Rep 2017 ; 7 : 46749.
5) 大石晃嗣ほか. クリオプレシピテート院内作製プロトコール. 日輸血細胞治療会誌 2016 ; 62 : 664-72.
6) Pishko AM, et al. Thrombocytopenia in pregnancy : Diagonosis and approach to management. Blood Rev 2020 ; 40 : 100638.
7) WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN) : an international, randomised, double-blind, placebo-controlled trial. Lancet 2017 ; 389 : 2105-16.
8) Todo Y, et al. Therapeutic application of C1 esterase inhibitor concentrate for clinical amniotic fluid embolism : a case report. Clin Case Rep 2015 ; 3 : 673-5.
9) Waters JH, et al. How do I perform cell salvage in obstetrics? Transfusion 2019 ; 59 : 2199-202.
10) Matsunaga S, et al. Fibrinogen for the management of critical obstetiric hemorrahage. J Obstet Gynaecol Res 2019 ; 45 : 13-21.
関博之ほか編. 産科危機的出血への対応. 東京 : メジカルビュー社 ; 2019.
大久保光夫. 前田平生. よくわかる輸血学 第3版. 東京 : 羊土社 ; 2018.
P.70 掲載の参考文献
1) 平成29年度厚生労働行政推進調査事業費補助金 (厚生労働科学特別研究事業) 無痛分娩の実態把握及び安全管理体制の構築についての研究 (研究代表者 海野信也). 無痛分娩の安全な提供体制の構築に関する提言. 2018.
2) 日本麻酔科学会. 局所麻酔薬中毒への対応プラクティカルガイド. 2017.

II章 症候編

P.76 掲載の参考文献
1) Sotiriadis A, et al. Threatened miscarriage : evaluation and management. BJM 2004 ; 329 : 152-5.
3) Augustin G, Majerovic M. Non-obstetrical acute abdomen during pregnancy. Eur J Obstet Gynecol Reprod Biol 2007 ; 131 : 4-12.
4) Mourad J, et al. Appendicitis in pregnancy : new information that contradicts long-held clinical beliefs. Am J Obstet Gynecol 2000 ; 182 : 1027-9.
急性腹症診療ガイドライン出版委員会編. 急性腹症ガイドライン 2015. 東京 : 医学書院 ; 2015.
日本産科婦人科学会, 日本産婦人科医会編・監. 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020.
Kilpatrick CC. Approach to acute abdominal pain in pregnant and postpartum women. In : UpToDate. Waltham : UpToDate Inc. https://www.uptodate.com (最終閲覧 2020年12月3日)
腹痛を「考える」会. 腹痛の「なぜ? 」がわかる本. 東京 : 医学書院 ; 2020.
ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 193 : Tubal Ectopic Pregnancy. Obstet Gynecol 2018 ; 131 : e91-103.
日本医学放射線学会編. 画像診断ガイドライン 2016年版. 東京 : 金原出版 ; 2016. p.429-30.
P.80 掲載の参考文献
1) Wang SM, et al. Low back pain during pregnancy : prevalence, risk factors, and outcomes. Obstet Gynecol 2004 ; 104 : 65-70.
2) Sneag DB, Benfo JA. Pregnancy-related low back pain. Orthopedics 2007 ; 30 : 839-45.
3) Beckmann CRB, et al. Maternal-fetal physiology. In : Obstetrics and Gynecology. 6th ed. Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins ; 2010. p.50.
4) Streffer C, et al. Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection. Ann ICRP 2003 ; 33 : 5-206.
5) International Commission on Radiological Protection. Pregnancy and medical radiation. ICRP Publication 84. Ann ICRP 2000 ; 30 : 1-43.
6) American College of Radiology. ACR Manual on Contrast Medica 2020. Reston : ACR Committee on Drugs and Contrast Media ; 2020. p.98.
7) Pearlman MD, et al. A prospective controlled study of outcome after trauma during pregnancy. Am J Obstet Gynecol 1990 ; 162 : 1 502-7.
8) Galliker G, et al. Low back pain in the emergency department : prevalence of serious spinal pathologies and diagnostic accuracy of red flags. Am J Med 2020 ; 133 : 60-72. e14.
9) 関沢明彦, 長谷川潤一編. 日本の妊産婦を救うために 2020. 東京 : 東京医学社 ; 2020. p.261-7.
10) Patterson TF, Andriole VT. Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am 1997 ; 11 : 593-608.
11) Smeill FM, et al. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2015 ; 8 : CD000490.
12) Kass EH. Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 1960 ; 105 : 194-8.
13) Wing DA, et al. Acute pyelonephritis in pregnancy : an 18-year retrospective analysis. Am J Obstet Gynecol 2014 ; 210 : 219. e1-6.
14) Han IH. Pregnancy and spinal problems. Curr Opin Obstet Gynecol 2010 ; 22 : 477-81.
15) Butler EL, et al. Symptomatic nephrolithiasis complicating pregnancy. Obstet Gynecol 2000 ; 96 : 753-6.
16) Tan UK, et al. Management of stones in abnormal situations. Urol Clin North Am 2013 ; 40 : 79-97.
17) Wu WH, et al. Pregnancy-related pelvic girdle pain (PPP), I : Terminology, clinical presentation, and prevalence. Eur Spine J 2004 ; 13 : 575-89.
18) Vleeming A, et al. European guidelines for the diagnosis and treatment of pelvic girdle pain. Eur spine J 2008 ; 17 : 794-819.
19) Mantle MJ, et al. Backache in pregnancy. Rhumatol Rehabil 1977 ; 16 : 95-101.
P.85 掲載の参考文献
1) 国際頭痛学会・頭痛分類委員会. 日本頭痛学会・国際頭痛分類委員会訳. 国際頭痛分類. 第3版. 東京 : 医学書院 ; 2018.
2) Robbins MS, et al. Acute headache diagnosis in pregnant women : a hospital-based study. Neurology 2015 ; 85 : 1024-30.
3) Meador KJ, et al, NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study) : a prospective observational study. Lancet 2013 ; 12 : 244-52.
4) 日本神経学会, 日本頭痛学会監. 慢性頭痛の診療ガイドライン 2013. 東京 : 医学書院 ; 2013.
5) Sances G, et al. Course of migraine during pregnancy and postpartum : a prospective study. Cephalalgia 2003 ; 23 : 197-205.
6) 日本脳卒中学会・脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015 [追補 2019]. 東京 : 協和企画 ; 2019.
P.92 掲載の参考文献
1) Franklin, et al. Is pulse pressure useful in predicting risk for coronary heart disease? : The Framingham Heart Study. Circulation 1999 ; 100 : 354-60.
2) Scime NV, et al. Pregnancy complications and risk of preterm birth according to maternal age : A population-based study of delivery hospitalizations in Alberta. Acta Obstet Gynecol Scand 2020 ; 99 : 459-68.
3) Sheen JJ, et al. Maternal age and preeclampsia outcomes during delivery hospitalizations. Am J Perinatol 2020 ; 37 : 44-52.
4) Wolf M, et al. Preeclampsia and future cardiovascular disease : potential role of altered angiogenesis and insulin resistence. J Clin Endocrinol Metab 2004 ; 89 : 6239-43.
5) McDonald SD, et al. Kidney disease after preeclampsia : a systemic review and meta-analysis. Am J Kidney Dis 2010 ; 55 : 1026-39.
6) Lamminpaa R, et al. Preeclampsia complicated by advanced maternal age : a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childbirth 2012 ; 12 : 47. doi : 10.1186/1471-2393-12-47.
7) Beukers F, et al. Blood pressure of 12-year-old children born after foetal growth restriction due to hypertensive disorders of pregnancy : relation to neonatal, life style, and family characteristics. Early Hum Dev 2019 ; 130 : 33-7.
8) Maher GM, et al. Association of hypertensive disorders of pregnancy with risk of neurodevelopmental disorders in offsrring : a systematic review and meta-analysis. JAMA Psychiatry 2018 ; 75 : 809-19.
9) Brown MA, et al. The detection, investigation and management of hypertension in pregnancy : full consensus statement. Aust N Z J Obstet Gynaecol 2000 ; 40 : 139-55.
10) Homer CS, et al. Non-proteinuric pre-eclampsia : a novel risk indicator in women with gestational hypertension. J Hypertens 2008 ; 26 : 295-302.
11) Malha L, et al. Secondary hypertension in pregnancy. Curr Hypertens Rep 2015 ; 17 : 53. doi : 10.1007/s11906-015-0563-z.
12) Okawa T, et al. Diagnosis and management of primary aldosteronism in pregnancy : case report and review of the literature. Am J Perinatol 2002 ; 19 : 31-6.
13) Neerhof MG, et al. Idiopathic aldosteronism in pregnancy. Obstet Gynecol 1991 ; 78 : 489-91.
14) Morton A. Primary aldosteronism and pregnancy. Pregnancy Hypertens 2015 ; 5 : 259-62.
15) Abdelmannan D, et al. Adrenal disorders in pregnancy. Endocrinol Metab Clin North Am 2011 ; 40 : 779-94.
16) Biggar MA, et al. Systemic review of phaeochromocytoma in pregnancy. Br J Surg 2013 ; 100 : 182-90.
17) Harper MA, et al. Phaeochromocytoma in pregnancy. Five cases and a review of the literatures. Br J Obstet Gynaecol 1989 ; 96 : 594-606.
18) Lenders JWM. Pheochromocytoma and pregnancy : a deceptive connection. Eur J Endocrinol 2012 ; 166 : 143-50.
19) Kamari Y, et al. Peripartum hypertension from pheocromocytoma : a rare and challenging entity. Am J Hypertens 2005 ; 18 : 1306-12.
20) Lekarev O, et al. Adrenal disease in pregnancy. Best Pract Res Clin Endocrinol Metab 2011 ; 25 : 959-73.
21) Tajika T, et al. Case report of a Cushing's syndrome patient with multiple pathologic fractures during pregnancy. J Orthop Sci 2002 ; 7 : 498-500.
23) Lindsay JR, et al. Cushing's syndrome during pregnancy : personal experience and review of the literature. J Clin Endocrinol Metab 2005 ; 90 : 3077-83.
24) Kamoun M, et al. Adrenal diseases during pregnancy : patholpgy, diagnosis and management strategies. Am J Med Sci 2014 ; 347 : 64-73.
25) Seki H. Balance of antiangiogenic and angiogenic factors in the context of preeclampsia. Acta Obstet Gynecol Scand 2014 ; 93 : 959-64.
27) Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002 ; 100 : 369-77.
28) 大野泰正. 分娩時高血圧に対する対応. 日妊娠高血圧会誌 2012 ; 20 : 31-3.
29) Sibai BM, et al. Eclampsia. I. Observations from 67 recent cases. Obstet Gynecol 1981 ; 58 : 609-13.
30) 日本妊娠高血圧学会編. 妊娠高血圧症候群の診療指針 2015. 東京 : メジカルビュー社 ; 2015. p.201-4.
31) Magee LA, et al. Hydralazine for treatment of severe hypertension in pregnancy : mata-analysis. BMJ 2003 ; 327 : 955-60.
32) Houlihan DD, et al. Anti-hypertensive therapy and the feto-placental circulation : effects on umbilical artery resistance. J Perinat Med 2004 ; 32 : 315-9.
33) Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996 ; 335 : 257-65.
34) Seki H, et al. Long-term treatment with nicardipine for severe pre-eclampsia. In J Gynaecol Obstet 2002 ; 76 : 135-41.
35) Matsumura H, et al. Placental transfer of intravenous nicardipine and disposition into breast milk during the control of hypertension in women with pre-eclampsia. Hypertens Pregnancy 2014 ; 33 : 93-101.
36) 日本産科婦人科学会, 日本産婦人科医会編・監. 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.172-6.
P.99 掲載の参考文献
1) Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) : much ado about nothing? Am J Obstet Gynecol 1990 ; 162 : 311-6.
2) Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004 ; 103 : 981-91.
3) Nelson DB, et al. Acute fatty liver of pregnancy : clinical outcomes and expected duration of recovery. Am J Obstet Gynecol 2013 ; 209 : 456 e1-7.
4) Ovadia C, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers : results of aggregate and individual patient data meta-analyses. Lancet 2019 ; 393 : 899-909.
P.104 掲載の参考文献
1) 日本産科婦人科学会, 日本産婦人科医会編・監. CQ005-1 妊婦の糖代謝異常スクリーニングと診断のための検査は? 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.22-4.
3) Guo RX, et al. Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels : case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J Obstet Gynaecol Res 2008 ; 34 : 324-30.
4) 清水一紀. 妊娠の糖尿病ケトアシドーシスの診断, 対処法は? 日本糖尿病・妊娠学会編. 妊婦の糖代謝異常 診療・管理マニュアル. 第2版. 東京 : メジカルビュー ; 2018. p.139-40.
5) 日本産科婦人科学会, 日本産婦人科医会編・監. CQ506 まれではあるが妊産婦死亡を起こし得る合併症は? 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.290-2.
6) 和栗雅子. 妊産褥婦の合併疾患への対処方法 糖尿病性ケトアシドーシス. 臨婦産 2019 ; 73 : 306-9.
7) 川崎英二ほか. 妊娠関連発症1型糖尿病に関する全国調査. 糖尿病と妊娠 2006 ; 6 : 104-7.
8) 今川彰久ほか. 1型糖尿病調査委員会報告-劇症1型糖尿病の新しい診断基準 (2012). 糖尿病 2012 ; 55 : 815-20.
P.111 掲載の参考文献
1) 岡井崇ほか. 委員会提案 胎児心拍数波形の分類に基づく分娩時胎児管理の指針 (2010年版). 日産婦誌 2010 ; 62 : 2068-73.
2) 安藤由美ほか. 帝王切開時の脊髄くも膜下麻酔後低血圧に対する昇圧薬投与の胎児臍帯血への影響. 麻酔 2012 ; 61 : 875-79.
3) Friedlander JD, et al. Fetal bradycardia and uterine hyperactivity following subarachnoid administration of fentanyl during labor. Reg Anesth 1997 ; 22 : 378-81.
4) 林玲子. 胎児, 出生児からみた無痛分娩. 日臨麻会誌 2012 ; 32 : 331-6.
5) Aldrich CJ, et al. The effect of maternal posture on fetal cerebral oxygenation during labour. Br J Obstet Gynaecol 1995 ; 102 : 14-9.
6) Carbonne B, et al. Maternal position during labor : effects on fetal oxygen saturation measured by pulse oximetry. Obstet Gynecol 1996 ; 88 : 797-800.
7) Simpson KR, James DC. Efficacy of intrauterine resuscitation techniques in improving fetal oxygen status during labor. Obstet Gynecol 2005 ; 105 : 1362-8.
8) Simpson KR. Intrauterine resuscitation during labor : should maternal oxygen administration be a first-line measure? Semin Fetal Neonatal Med 2008 ; 13 : 362-7.
9) Raghuraman N, et al. Effect of oxygen vs room air on intrauterine fetal resuscitation : a randomized noninferiority clinical trial. JAMA Pediatr 2018 ; 172 : 818-23.
10) Sayed Ahmed WA, et al. Optimal management of umbilical cord prolapse. Int J Womens Health 2018 ; 10 : 459-65.
P.118 掲載の参考文献
1) Guterres AP, et al. Total spinal following labour epidural analgesia managed with non-invasive ventilation. Anaesth Intensive Care 2010 ; 38 : 373-5.
2) Caliskan E, et al. Bedside cesarean section due to total spinal block after epidural anesthesia for labor pain. Int J Obstet Anesth 2006 ; 15 : 87-8.
3) 日本麻酔科学会. 局所麻酔薬中毒への対応プラクティカルガイド. 2017. https://anesth.or.jp/files/pdf/practical_localanesthesia.pdf (最終閲覧 2020年11月23日)
P.124 掲載の参考文献
1) 日本産婦人科医会. 妊産婦死亡報告事業 2010年~2016年に集積した事例の解析結果. 2018. http://www.jaog.or.jp/wp/wp-content/uploads/2018/09/123_20180912_1.pdf (最終閲覧 2020年11月20日)
2) WHO. Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva : World Health Organization ; 2011. p.20-4.
3) 日本神経学会監. 第13章 てんかんと女性. てんかん診療ガイドライン 2018. 東京 : 医学書院 ; 2018. p.133-43. https://www.neurology-jp.org/guidelinem/tenkan_2018.html (最終閲覧 2020年11月20日)
4) 日本高血圧学会高血圧治療ガイドライン作成委員会編. 第10章 女性の高血圧, 第12章 特殊条件下高血圧. 高血圧治療ガイドライン 2019. 東京 : ライフサイエンス出版 ; 2019. p.156-63, 168-79. http://www.jpnsh.jp/data/jsh2019/JSH2019_noprint.pdf. (最終閲覧 2020年11月20日)
5) Yoshida K, et al. Strokes associated with pregnancy and puerperium : a nationwide study by the Japan Stroke Society. Stroke 2017 ; 48 : 276-82.
6) 高松和弘ほか. 急性期脳卒中の実態 : 脳卒中の病型別にみた初発神経症状の頻度. 小林祥泰編. 脳卒中データバンク 2015. 東京 : 中山書店 ; 2015. p.18-9.
7) Wall HK, et al. Addressing stroke signs and symptoms through public education : the Stroke Heroes Act FAST campaign. Prev Chronic Dis 2008 ; 5 : A49.
8) 循環器画像技術研究会, 菊地達也. MR検査-II-頭部 MR検査でわかること・脳卒中 (脳梗塞). https://citec.kenkyuukai.jp/special/index.asp?id=25660 (最終閲覧 2020年11月20日)
10) Thomas SV. Neurological aspect of eclampsia. J Neurol Sci 1998 ; 155 : 37-43.
11) Ohno Y, et al. Management of eclampsia and stroke during pregnancy. Neurol Med Chir 2013 ; 53 : 513-9.
13) Vigil-De Gracia P, et al. Incidence of eclampsia with HELLP syndrome and associated mortality in Latin America. Int J Gynaecol Obstet 2015 ; 129 : 219-22.
14) Bloom BM, et al. The role of venous blood gas in the emergency department : a systematic review and meta-analysis. Eur J Emerg Med 2014 ; 21 : 81-8.
15) Byrne AL, et al. Peripheral venous and arterial blood gas analysis in adults : are they comparable? A systematic review and meta-analysis. Respirology 2014 ; 19 : 168-75.
16) Paul RH, et al. Changes in fetal heart rate-uterine contraction patterns associated with eclampsia. Am J Obstet Gynecol 1978 ; 130 : 165-9.
17) 日本妊娠高血圧学会編. VII 子癇CQ2子癇の管理法は? 妊娠高血圧症候群の診療指針2015 Best Practice Guide. 東京 : メジカルビュー社 ; 2015. p.139-42. https://minds.jcqhc.or.jp/n/cq/D0003276 (最終閲覧 2020年11月20日)
18) Yoshimatsu J, et al. Factors contributing to mortality and morbidity in pregnancy-associated intracerebral hemorrhage in Japan. J Obstet Gynecol Res 2014 ; 40 : 1267-73.
19) 日本妊娠高血圧学会編. VIII 特殊な病態 4. 脳卒中CQ脳卒中の診断と管理は? 妊娠高血圧症候群の診療指針 2015 Best Practice Guide. 東京 : メジカルビュー社 ; 2015. p.169-73. https://minds.jcqhc.or.jp/n/cq/D0003290 (最終閲覧 2020年11月20日)
P.131 掲載の参考文献
1) Begley CM, et al. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev 2019 ; 2 : CD007412. doi : 10.1002/14651858.CD007412.pub5.
2) 日本産科婦人科学会ほか. 産科危機的出血への対応指針 2017. 2017. http://www.jsog.or.jp/activity/pdf/shusanki_shishin2017.pdf
3) Roberts I, et al. The CRASH-2 trial : a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess 2013 ; 17 : 1-79.
4) WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN) : an international, randomised, double-blind, placebo-controlled trial. Lancet 2017 ; 389 : 2105-16.
5) Tuncalp O, et al. World Health Orgnization. New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynaecol Obstet 2013 ; 123 : 254-6.
6) American College of Obstetricians and Gynecologists. ACOG Practice Bulletin : Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006 : postpartum hemorrhage. Obstet Gynecol 2006 ; 108 : 1039-47.
7) Prevention and Management of Postpartum Haemorrhage : Green-top Guideline No. 52. BJOG 2017 ; 124 : e106-49.
8) Yorifuji T, et al. Balloon tamponade in atonic bleeding induces uterine contraction : attempt to quantify uterine stiffness using acoustic radiation force impulse elastography before and after balloon tamponade. Acta Obstet Gynecol Scand 2011 ; 90 : 1171-2.
9) Makino S, et al. Uterine balloon tamponade as a test to assess further treatment. Acta Obstet Gynecol Scand 2015 ; 94 : 556.
10) Takeda S, et al. A minimally invasive hemostatic strategy in obstetrics aiming to preserve uterine function and enhance the safety of subsequent pregnancies. Hypertens Res Pregnancy 2019 ; 7 : 9-15.
11) 日本IVR学会編. 産科危機的出血に対するIVR施行医のためのガイドライン 2017. 2018. http://www.jsir.or.jp/docs/sanka/2017sanka_GL180710.pdf
12) Badawy SZ, et al. Uterine artery embolization : the role in obstetrics and gynecology. Clin Imageng 2001 ; 25 : 288-95.
13) Vegas G, et al. Selective pelvic arterial embolization in the management of obstetric hemorrhage. Eur J Obstet Gynecol Reprod Biol 2006 ; 127 : 68-72.
14) Poggi SH, et al. Outcome of pregnancies after pelvic artery embolization for postpartum hemorrhage : retrospective cohort study. Am J Obstet Gynecol 2015 ; 213 : 576. e1-5.
15) Takeda J, et al. : Spontaneous uterine rupture at 32 weeks of gestation after previous uterine artery embolization. J Obstet Gynecol Res 2014 ; 40 : 243-6.
16) Sinha R, Roxby D. Change in transfusion practice in massively bleeding patients. Transfus Apher Sci 2011 ; 45 : 171-4.
17) Johansson PI, Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients : a before and after study. Vox Sang 2009 ; 96 : 111-8.
18) Baumann Kreuziger LM, et al. Not only in trauma patients : hospital-wide implementation of a massive transfusion protocol. Transfus Med 2014 ; 24 : 162-8.
19) Matsunaga S, et al. A retrospective analysis of transfusion management for obstetric hemorrhage in a Japanese obstetric center. ISRN Obstet Gynecol 2013 ; 2012 : 854064.
20) Gutierrez MC, et al. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center : a retrospective study. Int J Obstet Anesth 2012 ; 21 : 230-5.
21) Tanaka H, et al. Efficacy of transfusion with fresh-frozen plasma : red blood cell concentrate ratio of 1 or more for amniotic fluid embolism with coagulopathy : a case-control study. Transfusion 2016 ; 56 : 3042-6.
P.137 掲載の参考文献
1) 妊産婦死亡症例検討評価委員会 (厚生労働省科学研究班 : 池田智明), 日本産婦人科医会. 母体安全への提言 2018 vol. 9. 2019. p.8-14. 令和元年8月
2) Takeda J, Takeda S. Management of disseminated intravascular coagulation associated with placental abruption and measures to improve outcomes. Obstet Gynecol Sci 2019 ; 62 : 299-306.
3) Takeda J, et al. Hemostasis for massive hemorrhage during cesarean section. In : Schmolzer G, editors. Cesarean Delivery. IntechOpen ; 2019 (October 3rd 2019). doi : 10.5772/intechopen.86394. https://www.intechopen.com/online-first/hemostasisfor-massive-hemorrhage-during-cesarean-section (最終閲覧 2020年11月20日)
4) Takeda S, et al. A minimally invasive hemostatic strategy in obstetrics aiming to preserve uterine function and enhance the safety of subsequent pregnancies. Hypertens Res Pregnancy 2019 ; 7 : 9-15.
5) Takeda S, et al. Cesarean section for placenta previa and placenta previa accreta spectrum. Surg J (N Y) 2020 ; 6 : S110-21. doi : 10.1055/s-0039-3402036. Epub 2020 Mer 9. https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0039-3402036 (最終閲覧 2020年11月20日)
6) Takeda J, et al. Enclosing sutures technique for control of local bleeding in a case of placenta increta. J Obstet Gynaecol Res 2018 ; 44 : 1472-5.
7) Bakri YN, et al. Tamponade-balloon for obstetrical bleeding. Int J Gynecol Obstet 2001 ; 74 : 139-42.
8) Georgiou C. A review of current practice in using Balloon Tamponade Technology in the management of postpartum Evaluation of the effectiveness of metreurynters for balloon tamponade haemorrhage. Hypertens Res Pregnancy 2014 ; 2 : 1-10.
9) Yorifuji T, et al. Evaluation of the effectiveness of metreurynters for balloon tamponade. Hypertens Res in Pregnancy 2018 ; 6 : 26-9.
10) Takeda J, et al. Assessment of extravasation on ruptured uterine artery pseudoaneurysm using contrast-enhanced ultrasonography during uterine balloon tamponade. J Int Med Res 2019 Dec 20 ; 300060519893166. doi : 10.1177/0300060519893166.
11) B-Lynch C, et al. The B-Lynch surgical technique for the control of massive postpartum haemorrhage : an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol 1997 ; 104 : 372-5.
12) Makino S, et al. Hemostatic technique during cesarean section. Hypertens Res Pregnancy 2016 ; 4 : 6-10.
13) Takeda S. Education and training approaches for reducing maternal deaths in Japan. Hypertens Res Pregnancy 2018 ; 6 : 15-9.
P.143 掲載の参考文献
1) Ruys TP, et. al. Heart failure in pregnant women with cardiac disease : data from the ROPAC. Heart 2014 ; 100 : 231-8.
2) 筒井裕之ほか. 急性・慢性心不全診療ガイドライン (2017年改訂版). 日本循環器学会/日本心不全学会合同ガイドライン. 2018.
3) Demakis JG, et al. Peripartum cardiomyopathy. Circulation 1971 ; 44 : 964-8.
4) Sliwa K, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy : a position statement from the heart failure association of the European Society of Cardiology working group on peripartum cardiomyopathy. Eur J Heart Fail 2010 ; 12 : 767-78.
5) Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States : diagnosis, prognosis, and management. J Am Coll Cardiol 2011 ; 58 : 659-70.
6) Ghomian N, et al. Can brain natriuretic peptide predict cardiovascular complications in severe preeclampsia? A case-control study. Int J Reprod Biomed 2019 28 ; 17 : 271-8.
7) Hilfiker-Kleiner D, et al. Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 2007 ; 50 : 2354-5.
8) Sliwa K, et al. Evaluation of bromcriptine in treatment of acute severe peripartum cardiomyopathy. A proof-of-concept pilot study. Circulation 2010 ; 121 : 1465-73.
9) Meyer GP, et al. Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings : two case reports. J Med case reports 2010 ; 4 : 80.
10) Peacock IV WF, et al. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology 2007 ; 107 : 44-51.
11) Dickstein K, et al, ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008 ; 29 : 2388-442.
12) De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock : SOAP II Investigators. N Engl J Med 2010 ; 362 : 779-89.
13) Hilfiker-Kleiner D, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007 ; 128 : 589-600.
日本循環器学会学術委員会合同研究班. 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン (2018年改訂版). 2019.
P.147 掲載の参考文献
1) 日本産科婦人科学会, 日本産婦人科医会編・監. 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.108-10.
2) 厚生省医薬安全局. 高カロリー輸液療法施行時の重篤なアシドーシス. 医薬品等安全性情報 No. 144. 1997.
3) Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 189 : Nausea and vomiting of pregnancy. Obstet Gynecol 2018 ; 131 : e15-e30.
6) Matthews A, et al. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2015 : CD007575.
7) Boelig RC, et al. Interventions for treating hyperemesis gravidarum. Cochrane Database Syst Rev 2016 : CD010607.
8) Heitmann K, et al. Treatment of nausea in pregnancy : a cross-sectional multinational web-based study of pregnant women and new mothers. BMC Pregnancy Childbirth 2015 ; 15 : 321.
9) 小林隆夫ほか. 産婦人科領域における深部静脈血栓症/肺血栓塞栓症 : 1991年から2000年までの調査成績. 日本産婦人科・新生児血液会誌 2005 ; 14 : 1-24.

III章 疾患編

P.155 掲載の参考文献
1) NICE guideline [NG126] National Institute for Health and Care Excellence. Clinical Guidelines. Ectopic pregnancy and miscarriage : diagnosis and initial management. London : National Institute for Health and Care Excellence (UK) ; 2019. p.31.
2) Creanga AA, et al. Pregnancy-related mortality in the United States, 2011-2013. Obstet Gynecol 2017 ; 130 : 366-73.
3) Shaw JL, et al. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update 2010 ; 16 : 432-44.
4) Talbot P, Riveles K. Smoking and reproduction : the oviduct as a target of cigarette smoke. Reprod Biol Endocrinol 2005 ; 3 : 52.
5) Clayton HB, et al. Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol 2006 ; 107 : 595-604.
6) 日本産科婦人科学会, 日本産婦人科医会編・監. 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.115-8.
7) Ryo E, et al. Prompt diagnosis of ectopic pregnancy with the human chorionic gonadotropin test using exuded extract from endometrial curettings. Fertil Steril 2006 ; 85 : 1068-70.
8) Diagnosis and Management of Ectopic Pregnancy : Green-top Guideline No. 21. BJOG 2016 ; 123 : e15-55.
9) Hajenius PJ, et al. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev 2007 ; 2007 : CD000324.
10) Mol F, et al. Salpingotomy versus salpingectomy in women with tubal pregnancy (ESEP study) : an open-label, multicentre, randomised controlled trial. Lancet 2014 ; 383 : 1483-9.
11) Lipscomb GH, et al. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 1999 ; 341 : 1974-8.
12) van Mello NM, et al. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison. Hum Reprod 2013 ; 28 : 60-7.
P.160 掲載の参考文献
1) Bouyer J, et al. Sites of ectopic pregnancy : a 10 year population-based study of 1800 cases. Hum Reprod 2002 ; 17 : 3224-30.
2) Unshakov FB, et al. Cervical pregnancy : past and future. Obstet Gynecol Surv 1997 ; 52 : 45-59.
3) Rotas MA, et al. Caesarean scar ectopic pregnancies : etiology, diagnosis, and management. Obstet Gynecol 2006 ; 107 : 1373-81.
4) Vela G, Tulandi T. Cervical pregnancy : the importance of early diagnosis and treatment. J Minim Invasive Gynecol 2007 ; 14 : 481-4.
5) Vial Y, et al. Pregnancy in a caesarean scar. Ultrasound Obstet Gynecol 2000 ; 16 : 592-3.
6) Lipscomb GH. Medical therapy for ectopic pregnancy. Semin Reprod Med 2007 ; 25 : 93-8.
7) Stovall TG, et al. Single-dose methotrexate treatment of ectopic pregnancy. Obstet Gynecol 1991 ; 77 : 754-7.
8) 南波美沙ほか. 帝王切開瘢痕部の初期妊娠に対して経腟的子宮内容吸引除去術とフォーリーカテーテル留置による圧迫止血を行った2例. 静岡産婦会誌 2017 ; 6 : 75-81.
P.164 掲載の参考文献
1) Abbasi N, et al. Management and outcomes of acute appendicitis in pregnancy-population-based study of over 7000 cases. BJOG 2014 ; 121 : 1509-14.
2) Mahmoodian S. Appendicitis complicating pregnancy. South Med J 1992 ; 85 : 19-24.
3) Rao PM, et al. Sensitivity and specificity of the individual CT signs of appendicitis : experience with 200 helical appendiceal CT examinations. J Comput Assist Tomogr 1997 ; 21 : 686-92.
4) Yilmaz HG, et al. Acute appendicitis in pregnancy-risk factors associated with principal outcomes : a case control study. Int J Surg 2007 ; 5 : 192-7.
5) Wallace CA, et al. Influence of imaging on the negative appendectomy rate in pregnancy. J Gastrointest Surg 2008 ; 12 : 46-50.
6) Prodromidou A, et al. Outcomes after open and laparoscopic appendectomy during pregnancy : a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2018 ; 225 : 40-50.
7) Rollins MD, et al. Laparoscopy for appendicitis and cholelithiasis during pregnancy : a new standard of care. Surg Endosc 2004 ; 18 : 237-41.
P.167 掲載の参考文献
1) World Health Organization. Magnesium sulfate for fetal protection against neurological complications. In : WHO recommendations on interventions to improve preterm birth outcomes. Geneva : World Health Organization ; 2015.
P.172 掲載の参考文献
1) 日本アレルギー学会編. アナフィラキシーガイドライン. 東京 : 日本アレルギー学会 ; 2014. p.1. https://anaphylaxis-guideline.jp/pdf/anaphylaxis_guideline.PDF (最終閲覧 2020年12月18日)
2) 海老澤元宏. アナフィラキシーガイドライン : 初期対応と再発予防の重要性. アレルギー 2015 ; 64 : 24-31.
3) 中村陽一. アナフィラキシーガイドライン. アレルギー 2018 ; 67 : 17-23.
5) Simons FE, Schattz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012 ; 130 : 597-606.
6) 日本輸血・細胞治療学会. 輸血製剤副反応動向 2017. 2019. http://yuketsu.jstmct.or.jp/wp-content/uploads/2019/07/88ca0abdf1a074260e3792999ca832c4.pdf (最終閲覧 2020年12月18日)
7) 厚生労働省. 平成30年 (2018) 人口動態統計.
8) Fedorowicz Z, et al. Histamine H2-receptor antagonists for urticaria. Cochrane Datebase Syst Rev 2012 ; 2012 : CD008596. doi : 10.1002/14651858. CD008596.pub2.
P.178 掲載の参考文献
1) 厚生労働省. 保健福祉動向調査 (全国調査). 2003.
2) 伊藤真也, 村島温子編. 妊娠と授乳 第3版. 東京 : 南山堂 ; 2020. p.6, 7.
3) Mahadevan U, et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013 ; 11 : 286-92 ; quiz e24.
4) Demissie K, et al. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 1998 ; 158 : 1091-5.
5) Murphy VE, Gibson PG. Asthma in pregnancy. Clin Chest Med 2011 ; 32 : 93-110.
6) Kowalski ML, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) -classification, diagnosis and management : review of the EAACI/ENDA (#) and GA2LEN/HANNA*. Allergy 2011 ; 66 : 818-29.
7) Gluck PA, Gluck JC. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin 2005 ; 21 : 1075-84.
8) Park-Wyllie L, et al. Birth defects after maternal exposure to corticosteroids : prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000 ; 62 : 385-92.
9) Gur C, et al. Pregnancy outcome after first trimester exposure to corticosteroids : a prospective controlled study. Reprod Toxicol 2004 ; 18 : 93-101.
10) Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology 1997 ; 56 : 335-40.
11) Skuladottir H, et al. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol 2014 ; 100 : 499-506.
12) Beitins IZ, et al. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972 ; 81 : 936-45.
13) Anderson GG, et al. Placental transfer of methylprednisolone following maternal intravenous administration. Am J Obstet Gynecol 1981 ; 140 : 699-701.
14) Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977 ; 127 : 264-7.
15) Cavero-Carbonell C, et al. Fetal exposure to montelukast and congenital anomalies : a population based study in Denmark. Birth Defects Res 2017 ; 109 : 452-9.
16) Sarkar M, et al. Montelukast use during pregnancy : a multicentre, prospective, comparative study of infant outcomes. Eur J Clin Pharmacol 2009 ; 65 : 1259-64.
18) Moretti ME, et al. Fetal safety of loratadine use in the first trimester of pregnancy : a multicenter study. J Allergy Clin Immunol 2003 ; 111 : 479-83.
19) Kallen B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med 2002 ; 11 : 146-52.
20) Schatz M, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 1997 ; 100 : 301-6.
21) Schatz M, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol 2004 ; 113 : 1040-5.
22) Eltonsy S, et al. Beta2-agonists use during pregnancy and the risk of congenital malformations. Birth Defects Res A Clin Mol Teratol 2011 ; 91 : 937-47.
23) Namazy J, et al. The Xolair Pregnancy Registry (EXPECT) : the safety of omalizumab use during pregnancy. J Allergy Clin Immunol 2015 ; 135 : 407-12.
24) Heinonen OP, et al. Birth Defects and Drugs in Pregnancy. Littleton : Publishing Sciences Group ; 1977.
P.184 掲載の参考文献
1) Tietgen S, Leinung MC. Thyroid storm. Med Clin North Am 1995 ; 79 : 169-84.
2) Akamizu T, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid 2012 ; 22 : 661-79.
3) 赤水尚史ほか. 甲状腺クリーゼ 診断基準 (第2版). 2012 ; 5-6. http://www.j-endo.jp/uploads/files/edu/thyroid_storm_or_crisis-guidelines_digest.pdf http://www.japanthyroid.jp/doctor/img/thyroid_storm_or_crisis.pdf (最終閲覧 2020年12月10日)
4) Satoh T, et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition). Endocr J 2016 ; 63 : 1025-64.
5) 日本甲状腺学会, 日本内分泌学会編. 甲状腺クリーゼ診療ガイドライン 2017. 東京 : 南江堂 : 2017. p.1-112.
6) 日本甲状腺学会, 日本内分泌学会編. 甲状腺クリーゼ診療ガイドライン 2017 Digest版. http://www.j-endo.jp/uploads/files/edu/thyroid_storm_or_crisis-guidelines_digest.pdf http://www.japanthyroid.jp/doctor/img/thyroid_storm_or_crisis.pdf (最終閲覧 2020年12月10日)
P.190 掲載の参考文献
1) Faiz AS, Ananth CV. Etiology and risk factors for placenta previa : an overview and meta-analysis of observational studies. J Matern-Fetal Neonatal Med 2003 ; 13 : 175-90.
2) Romundstad LB, et al. Increased risk of placenta previa in pregnancies following IVF/ICSI : a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod 2006 ; 21 : 2353-8.
3) 新垣達也. 母児の予後からみた前置胎盤症例における娩出のタイミング. 日周産期・新生児会誌 2016 ; 51 : 28-9.
4) Besinger RE, et al. The effect of tocolytic use in the management of symptomatic placenta previa. Am J Obstet Gynecol 1995 ; 172 : 1770-5 ; discussion 5-8.
5) Bhide A, et al. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG 2003 ; 110 : 860-4.
P.193 掲載の参考文献
1) Holbrook BD, Phelan ST. Umbilical cord prolapse. Obstet Gynecol Clin North Am 2013 ; 40 : 1-14.
2) Kahana B, et al. Umbilical cord prolapse and perinatal outcomes. Int J Gynaecol Obstet 2004 ; 84 : 127-32.
3) Murphy DJ, MacKenzie IZ. The mortality and morbidity associated with umbilical cord prolapse. Br J Obstet Gynaecol 1995 ; 102 : 826-30.
4) Usta IM, et al. Current obstetrical practice and umbilical cord prolapse. Am J Perinatol 1999 ; 16 : 479-84.
5) Hasegawa J, et al. Obstetric risk factors for umbilical cord prolapse : a nationwide population-based study in Japan. Arch Gynecol Obstet 2016 ; 294 : 467-72.
6) Hasegawa J, et al. Clinical risk factors for poor neonatal outcomes in umbilical cord prolapse. J Matern Fetal Neonatal Med 2015 ; 29 : 1652-6.
7) Barrett JM. Funic reduction for the management of umbilical cord prolapse. Am J Obstet Gynecol 1991 ; 165 : 654-7.
P.198 掲載の参考文献
1) Barigye O, et al. High risk of unexpected late fetal death in monochorionic twins despite intensive ultrasound surveillance : a cohort study. PLoS Med 2005 ; 2 : e172.
2) Simoes T, et al. Prospective risk of intrauterine death of monochorionic-diamniotic twins. Am J Obstet Gynecol 2006 ; 195 : 134-9.
3) Yoshida K, Matayoshi K. A study on prognosis of surviving cotwin. Acta Genet Med Gemellol (Roma) 1990 ; 39 : 383-8.
4) 末原則幸. 双胎一児死亡の取り扱い. 周産期医学 2005 ; 35 : 973-7.
5) 村越毅ほか. 妊娠初期から管理した 1 絨毛膜 2 羊膜双胎の予後についての検討. 日周産期・新生児会誌 2006 ; 42 : 321.
6) Nakayama S, et al. Perinatal outcome of monochorionic diamniotic twin pregnancies managed from early gestation at a single center. J Obstet Gynaecol Res 2012 ; 38 : 692-7.
8) Ong SS, et al. Prognosis for the co-twin following single-twin death : a systematic review. BJOG 2006 ; 113 : 992-8.
11) Chang YL, et al. Clinical outcome and placental territory ratio of monochorionic twin pregnancies and selective intrauterine growth restriction with different types of umbilical artery Doppler. Prenat Diagn 2009 ; 29 : 253-6.
12) Bajoria R, et al. Outcome of twin pregnancies complicated by single intrauterine death in relation to vascular anatomy of the monochorionic placenta. Hum Reprod 1999 ; 14 : 2124-30.
13) Tanawattanacharoen S, et al. Intrauterine rescue transfusion in monochorionic multiple pregnancies with recent single intrauterine death. Prenat Diagn 2001 ; 21 : 274-8.
14) Nicolini U, Poblete A. Single intrauterine death in monochorionic twin pregnancies. Ultrasound Obstet Gynecol 1999 ; 14 : 297-301.
15) Hillman SC, et al. Co-twin prognosis after single fetal death : a systematic review and meta-analysis. Obstet Gynecol 2011 ; 118 : 928-40.
16) Mackie FL, et al. Prognosis of the co-twin following spontaneous single intrauterine fetal death in twin pregnancies : a systematic review and meta-analysis. BJOG 2019 ; 126 : 569-578.
17) Fusi L, Gordon H. Twin pregnancy complicated by single intrauterine death. Problems and outcome with conservative management. Br J Obstet Gynaecol 1990 ; 97 : 511-6.
18) 日本産科婦人科学会周産期委員会. ハイリスク胎児 新生児の予後に関する検討小委員会報告. 日産婦誌 1996 : 48 : 1032-3.
19) 日本産科婦人科学会周産期委員会. ハイリスク胎児 新生児の予後に関する検討小委員会報告. 日産婦誌 1997 : 49 : 944.
20) Saito K, et al. Perinatal outcome and management of single fetal death in twin pregnancy : a case series and review. J Perinat Med 1999 ; 27 : 473-7.
21) Quintero RA, et al. Fetoscopic demonstration of perimortem feto-fetal hemorrhage in twin-twin transfusion syndrome. Ultrasound Obstet Gynecol 2002 ; 20 : 638-9.
22) Fusi L, et al. Acute twin-twin transfusion : a possible mechanism for brain-damaged survivors after intrauterine death of a monochorionic twin. Obstet Gynecol 1991 ; 78 : 517-20.
24) Benirschke K. Intrauterine death of a twin : mechanisms, implications for surviving twin, and placental pathology. Semin Diagn Pathol 1993 ; 10 : 222-31.
27) Pasquini L, et al. Management of other complications specific to monochorionic twin pregnancies. Best Pract Res Clin Obstet Gynaecol 2004 ; 18 : 577-99.
28) Senat MV, et al. Management of single fetal death in twin-to-twin transfusion syndrome : a role for fetal blood sampling. Ultrasound Obstet Gynecol 2002 ; 20 : 360-3.
29) Nakata M, et al. A case of monochorionic twin pregnancy complicated with intrauterine single fetal death with successful treatment of intrauterine blood transfusion in the surviving fetus. Fetal Diagn Ther 2006 ; 22 : 7-9.
P.204 掲載の参考文献
1) 日本産科婦人科学会, 日本産婦人科医会編・監. CQ308 常位胎盤早期剥離 (早剥) の診断・管理は? 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.164-7.
2) Ananth CV, et al. An international contrast of rates of placental abruption : an age-period-cohort analysis. PLoS One 2015 ; 10 : e0125246.
3) 中井章人ほか. 脳性麻痺を予防する常位胎盤早期剥離の早期診断と対処法. 周産期医学 2018 ; 48 : 313-7.
4) Cunningham F, et al. Placental abruption. In : Williams Obstetrics, 25th ed. New York : McGraw-Hill Education ; 2018. p.767-73.
5) 日本医療機能評価機構産科医療補償制度再発防止委員会編. 分析対象事例の概況. 第10回産科医療補償制度再発防止に関する報告書. 東京 : 日本医療機能評価機構 ; 2020. http://www.sanka-hp.jcqhc.or.jp/documents/prevention/report/pdf/Saihatsu_Report_10_All.pdf (最終閲覧 2020年12月7日)
6) 妊産婦死亡症例検討評価委員会, 日本産婦人科医会. 母体安全への提言 2019 vol. 10. 2020. https://www.jaog.or.jp/wp/wp-content/uploads/2020/09/botai_2019.pdf (最終閲覧 2020年12月7日)
7) Tikkanen M. Placental abruption : epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand 2011 ; 90 : 140-9.
8) Shinde GR, et al. Diagnostic performance of ultrasonography for detection of abruption and its clinical correlation and maternal and foetal outcome. J Clin Diagn Res 2016 ; 10 : QC04-7.
9) Tveit JV, et al. Reduction of late stillbirth with the introduction of fetal movement information and guidelines- a clinical quality improvement. BMC Pregnancy Childbirth 2009 ; 9 : 32. doi : 10.1186/1471-2393-9-32.
P.209 掲載の参考文献
2) Ananth CV, et al. Placental abruption among singleton and twin births in the United States : risk factor profiles. Am J Epidemiol 2001 ; 153 : 771-8.
3) Pritchard JA, Brekken AL. Clinical and laboratory studies on severe abruptio placentae. Am J Obstet Gynecol 1967 ; 97 : 681-700.
4) Chamberlain G, Steer P. ABC of labour care : obstetric emergencies. BMJ 1999 ; 318 : 1342-5.
5) Abruptio placentae. In : Cunningham FG, et al, editors. Williams Obstetrics. 25 ed. New York : McGraw-Hill Education ; 2018. p.767-73.
6) 日本産科婦人科学会, 日本産婦人科医会編・監. CQ308 常位胎盤早期剥離 (早剥) の診断・管理は? 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.164-7.
7) 川名有紀子ほか. 子宮内胎児死亡を伴う常位胎盤早期剥離症例の分娩様式からみた予後の検討. 日周産期・新生児会誌 2012 ; 48 : 22-6.
8) Oyelese Y, Ananth CV. Placedntal abruption : Management and long-term prognosis. 2019. In : UpToDate [online].
P.215 掲載の参考文献
1) Fitzpatrick KE, et al. Risk factors, management, and outcomes of amniotic fluid embolism : A multicountry, population-based cohort and nested case-control study. PLoS Med 2019 ; 16 : e1002962.
2) 妊産婦死亡症例検討評価委員会, 日本産婦人科医会. 妊産婦死亡原因. 母体安全への提言 2019. Vol 10. 2020. p.10-8.
3) Abenhaim HA, et al. Incidence and risk factors of amniotic fluid embolisms : a population-based study on 3 million births in the United States. Am J Obstet Gynecol 2008 ; 199 : 49. e1-8
4) Funk M, et al. Pulmonary vascular obstruction not involved in amniotic fluid embolism. Am J Obstet Gynecol 2018 ; 218 : 460-1.
5) Furuta N, et al. Immunohistochemical detection of meconium in the fetal membrane, placenta and umbilical cord. Placenta 2012 ; 33 : 24-30.
6) Clark SL, et al. Amniotic fluid embolism : analysis of the national registry. Am J Obstet Gynecol 1995 ; 172 : 1158-69.
7) Kanayama N, et al. Determining zinc coproporphyrin in maternal plasma : a new method for diagnosing amniotic fluid embolism. Clin Chem 1992 ; 38 : 526-9.
8) Pacheco LD, et al. Amniotic fluid embolism : principles of early clinical management. Am J Obstet Gynecol 2020 ; 222 : 48-52.
9) Viau-Lapointe JN, Filewod N. Extracorporeal therapies for amniotic fluid embolism. Obstet Gynecol 2019 ; 134 : 989-94.
P.221 掲載の参考文献
1) Knight M. Uterine rupture is rarer than previously thought. j UKOSS j NPEU [Internet]. Npeu. ox. ac. uk [cited 4 June 2018]. 2018. Available from : https://www.npeu.ox.ac.uk/ukoss/news/31-uterine-ruptureis-rarer-than-previously-thought (最終閲覧 2020年12月9日)
2) Makino S, et al. National survey of uterine rupture in Japan : Annual report of Perinatology Committee, Japan Society of Obstetrics and Gynecology, 2018. J Obstet Gynaecol Res 2019 ; 45 : 763-5.
3) Gambacorti-Passerini Z, et al. Trial of labor after myomectomy and uterine rupture : a systematic review. Acta Obstet Gynecol Scand 2016 ; 95 : 724-34.
4) Thisted DL, et al. Uterine rupture without previous caesarean delivery : a population-based cohort study. Eur J Obstet Gynecol Reprod Biol 2015 ; 195 : 151-5.
5) Tanos V, Toney ZA. Uterine scar rupture- Prediction, prevention, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol 2019 ; 59 : 115-31.
6) Vlemminx MW, et al. Tocogram characteristics of uterine rupture : a systematic review. Arch Gynecol Obstet 2017 ; 295 : 17-26.
7) 日本母体救命システム普及協議会 (J-CMELS) 総監. 母体救命アドバンスガイドブック. 東京 : へるす出版 ; 2017. p.99, 146.
P.227 掲載の参考文献
1) 中西美紗緒, 矢野哲. 腟壁裂傷縫合術, 会陰裂傷縫合術. 産と婦 2014 ; 81 : 77-82.
2) 佐藤秀平. 頸管裂傷縫合術. 産と婦 2014 ; 81 : 69-76.
3) Tsumagari A, et al. Clinical characteristics, treatment indications and treatment algorithm for post-partum hematomas. J Obstet Gynaecol Res 2019 ; 45 : 1127-33.
4) Youssef A, et al. Two- and three-dimensional transperineal ultrasound as complementary tool in management of vaginal hematoma. Ultrasound Obstet Gynecol 2019 ; 53 : 272-3.
5) Distefano M, et al. Selective arterial embolization as a first-line treatment for postpartum hematomas. Obstet Gynecol 2013 ; 121 : 443-7.
P.231 掲載の参考文献
1) Coad SL, et al. Risks and consequences of puerperal uterine inversion in the United States, 2004 through 2013. Am J Obstet Gynecol 2017 ; 217 : 377. e1-377. e6.
2) Witteveen T, et al. Puerperal uterine inversion in the Netherlands : a nationwide cohort study. Acta Obstet Gynecol Scand 2013 ; 92 : 334-7.
3) Lipitz S, Frenkel Y. Puerperal inversion of the uterus. Eur J Obstet Gynecol Reprod Biol 1988 ; 27 : 271-4.
4) Livingston SL, et al. Chronic uterine inversion at 14 weeks postpartum. Obstet Gynecol 2007 ; 109 : 555-7.
5) Johnson AB. A new concept in the replacement of the inverted uterus and a report of nine cases. Am J Obstet Gynecol 1949 ; 57 : 557-62.
6) Harris BA Jr. Acute puerperal inversion of the uterus. Clin Obstet Gynecol 1984 ; 27 : 134-8.
7) Huntington JL, et al. Abdominal reposition in acute inversion of the puerperal uterus. Am J Obstet Gynecol 1928 ; 15 : 34-40.
8) Haultain FW. Abdominal hysterotomy for chronic uterine inversion. Proc R Soc Med 1908 ; 1 : 279-90.
P.237 掲載の参考文献
1) Panchal AR, et al. Part 3 : Adult Basic and Advanced Life Support : 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2020 ; 142 : S366-468.
2) Katz VL, et al. Perimortem cesarean delivery. Obstet Gynecol 1986 ; 68 : 571-576.
3) Einav S, et al. Maternal cardiac arrest and perimortem cesarean delivery ; evidence or expert based? Resuscitation 2012 ; 83 : 1191-200.
4) 妊産婦死亡症例検討評価委員会, 日本産婦人科医会. 母体安全への提言 2010. 2011. http://www.jaog.or.jp/sep2012/diagram/notes/botai_2010.pdf (最終閲覧 2020年12月8日)
5) 日本産科婦人科学会, 日本産婦人科医会編・監. CQ903-1 突然発症した妊産婦の心停止 (状態) への対応は? 産婦人科診療ガイドライン産科編 2014. 東京 : 日本産科婦人科学会 ; 2014. p.387-91.
6) 日本産科婦人科学会, 日本産婦人科医会編・監. CQ903-1 突然発症した妊産婦の心停止 (状態) への対応は? 産婦人科診療ガイドライン産科編 2020. 東京 : 日本産科婦人科学会 ; 2020. p.377-9.
7) 日本母体救命システム普及協議会 (J-CIMELS) 総監. 母体救命アドバンスガイドブックJ-MELS. 東京 : へるす出版 ; 2017. p.207-28.
8) Katz V, et al. Perimortem cesarean delivery : were our assumptions correct? Am J Obstet Gynecol 2005 ; 192 : 1916-20.
9) Benson MD, et al. Maternal collapse : Challenging the four-minute rule. EBioMedicine 2016 ; 6 : 253-7.
10) Kobori S, et al Utility and limitations of perimortem cesarean section : a nationwide survey in Japan. J Obstet Gynaecol Res 2019 ; 45 : 325-30.
11) Beckett VA, et al. The CAPS Study : incidence, management and outcomes of cardiac arrest in pregnancy in the UK : a prospective, descriptive study. BJOG 2017 ; 124 : 1374-81.

最近チェックした商品履歴

Loading...